Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis– Data from 14 European Countries: Data from 14 European Countries

Gareth T Jones; Ovidiu Rotariu; Brigitte Michelsen; Bente Glintborg; Bjorn Gudbjornsson; Arni J Geirsson; Heikki Relas; Pia  Isomäki; Jakub Závada; Karel Pavelka; Žiga Rotar; Matija Tomšič; Michael John Nissen; Adrian Ciurea; Catalin Codreanu; Johan Karlsson Wallman; Eirik K. Kristianslund; Simon Horskjær Rasmussen; Lykke Midtbøll Ørnbjerg; Maria José Santos; Mikkel Østergaard; Merete Lund Hetland; Gary J Macfarlane

Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis– Data from 14 European Countries: Data from 14 European Countries

Gareth T Jones, Ovidiu Rotariu, Brigitte Michelsen, Bente Glintborg, Bjorn Gudbjornsson, Arni J Geirsson, Heikki Relas, Pia Isomäki, Jakub Závada, Karel Pavelka, Žiga Rotar, Matija Tomšič, Michael John Nissen, Adrian Ciurea, Catalin Codreanu, Johan Karlsson Wallman, Eirik K. Kristianslund, Simon Horskjær Rasmussen, Lykke Midtbøll Ørnbjerg, Maria José SantosMikkel Østergaard, Merete Lund Hetland, Gary J Macfarlane

Department for Rheumatology and Spine Diseases

Abstract

Background/Purpose:
In axial spondyloarthritis (axSpA) much attention has been focused on pharmacological management, including tumour necrosis factor inhibitors (TNFi), as a means to reducing inflammation, and improving function and quality of life. However studies have demonstrated that even with successful control of inflammation symptoms such as pain and fatigue, which have an important impact on quality of life, can remain. The addition of non-pharmacological therapy,
including the modification of adverse lifestyle factors, may offer the potential to enhance treatment outcomes in axial spondyloarthritis (axSpA)

Original language	English
Publication date	2022
Publication status	Published - 2022
Event	ACR 2022 - Philadelphia Duration: 10 Nov 2022 → 14 Nov 2022

Conference

Conference	ACR 2022
City	Philadelphia
Period	10/11/2022 → 14/11/2022

Fingerprint

Dive into the research topics of 'Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis– Data from 14 European Countries: Data from 14 European Countries'. Together they form a unique fingerprint.

Cite this

Jones, G. T., Rotariu, O., Michelsen, B., Glintborg, B., Gudbjornsson, B., Geirsson, A. J., Relas, H., Isomäki, P., Závada, J., Pavelka, K., Rotar, Ž., Tomšič, M., Nissen, M. J., Ciurea, A., Codreanu, C., Wallman, J. K., Kristianslund, E. K., Rasmussen, S. H., Ørnbjerg, L. M., ... Macfarlane, G. J. (2022). Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis– Data from 14 European Countries: Data from 14 European Countries. Arthritis & Reumatology Vol. 74, number S9, p. 2988. Abstract from ACR 2022, Philadelphia.

Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis– Data from 14 European Countries: Data from 14 European Countries. / Jones, Gareth T; Rotariu, Ovidiu; Michelsen, Brigitte et al.
2022. Arthritis & Reumatology Vol. 74, number S9, p. 2988 Abstract from ACR 2022, Philadelphia.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Jones, GT, Rotariu, O, Michelsen, B , Glintborg, B, Gudbjornsson, B, Geirsson, AJ, Relas, H, Isomäki, P, Závada, J, Pavelka, K, Rotar, Ž, Tomšič, M, Nissen, MJ, Ciurea, A, Codreanu, C, Wallman, JK, Kristianslund, EK, Rasmussen, SH, Ørnbjerg, LM, Santos, MJ, Østergaard, M , Hetland, ML & Macfarlane, GJ 2022, 'Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis– Data from 14 European Countries: Data from 14 European Countries', ACR 2022, Philadelphia, 10/11/2022 - 14/11/2022 pp. Arthritis & Reumatology Vol. 74, number S9, p. 2988.

@conference{7442b7a7bebf4bf2a68311345819ab05,

title = "Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis– Data from 14 European Countries: Data from 14 European Countries",

abstract = "Background/Purpose: In axial spondyloarthritis (axSpA) much attention has been focused on pharmacological management, including tumour necrosis factor inhibitors (TNFi), as a means to reducing inflammation, and improving function and quality of life. However studies have demonstrated that even with successful control of inflammation symptoms such as pain and fatigue, which have an important impact on quality of life, can remain. The addition of non-pharmacological therapy,including the modification of adverse lifestyle factors, may offer the potential to enhance treatment outcomes in axial spondyloarthritis (axSpA)",

author = "Jones, {Gareth T} and Ovidiu Rotariu and Brigitte Michelsen and Bente Glintborg and Bjorn Gudbjornsson and Geirsson, {Arni J} and Heikki Relas and Pia Isom{\"a}ki and Jakub Z{\'a}vada and Karel Pavelka and {\v Z}iga Rotar and Matija Tom{\v s}i{\v c} and Nissen, {Michael John} and Adrian Ciurea and Catalin Codreanu and Wallman, {Johan Karlsson} and Kristianslund, {Eirik K.} and Rasmussen, {Simon Horskj{\ae}r} and {\O}rnbjerg, {Lykke Midtb{\o}ll} and Santos, {Maria Jos{\'e}} and Mikkel {\O}stergaard and Hetland, {Merete Lund} and Macfarlane, {Gary J}",

note = "COPECARE; ACR 2022 ; Conference date: 10-11-2022 Through 14-11-2022",

year = "2022",

language = "English",

pages = "Arthritis & Reumatology Vol. 74, number S9, p. 2988",

}

TY - ABST

T1 - Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis– Data from 14 European Countries

T2 - ACR 2022

AU - Jones, Gareth T

AU - Rotariu, Ovidiu

AU - Michelsen, Brigitte

AU - Glintborg, Bente

AU - Gudbjornsson, Bjorn

AU - Geirsson, Arni J

AU - Relas, Heikki

AU - Isomäki, Pia

AU - Závada, Jakub

AU - Pavelka, Karel

AU - Rotar, Žiga

AU - Tomšič, Matija

AU - Nissen, Michael John

AU - Ciurea, Adrian

AU - Codreanu, Catalin

AU - Wallman, Johan Karlsson

AU - Kristianslund, Eirik K.

AU - Rasmussen, Simon Horskjær

AU - Ørnbjerg, Lykke Midtbøll

AU - Santos, Maria José

AU - Østergaard, Mikkel

AU - Hetland, Merete Lund

AU - Macfarlane, Gary J

N1 - COPECARE

PY - 2022

Y1 - 2022

N2 - Background/Purpose: In axial spondyloarthritis (axSpA) much attention has been focused on pharmacological management, including tumour necrosis factor inhibitors (TNFi), as a means to reducing inflammation, and improving function and quality of life. However studies have demonstrated that even with successful control of inflammation symptoms such as pain and fatigue, which have an important impact on quality of life, can remain. The addition of non-pharmacological therapy,including the modification of adverse lifestyle factors, may offer the potential to enhance treatment outcomes in axial spondyloarthritis (axSpA)

AB - Background/Purpose: In axial spondyloarthritis (axSpA) much attention has been focused on pharmacological management, including tumour necrosis factor inhibitors (TNFi), as a means to reducing inflammation, and improving function and quality of life. However studies have demonstrated that even with successful control of inflammation symptoms such as pain and fatigue, which have an important impact on quality of life, can remain. The addition of non-pharmacological therapy,including the modification of adverse lifestyle factors, may offer the potential to enhance treatment outcomes in axial spondyloarthritis (axSpA)

M3 - Conference abstract for conference

SP - Arthritis & Reumatology Vol. 74, number S9, p. 2988

Y2 - 10 November 2022 through 14 November 2022

ER -